Uptrend Under Pressure 93
Institutional selling is building — 7 distribution days in the last 25 sessions. Severe risk · 93/100 · 7 distribution days (SPY) Sep 11 Full briefing →
View
Simple research view

REGN · Regeneron Pharmaceuticals, Inc.

$793.26 -1.78% Sep 10 close
Detected setup Cup & Handle · Setup Score 55/100

Stand aside — setup invalidated

Setup score 55, but price closes below stop $830.47 — stand aside until the condition resets.

1 independent risk warning also present. Review before relying on the bullish setup.

Ask about REGN

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

$REGN

Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc. is a large-cap Pharmaceuticals: Major company in the Health Technology sector with a market cap of $75B.

Health Technology Pharmaceuticals: Major stock Stage 2 · Advancing Base 3+
$793.26 latest close
Join to Watchlist $REGN Share card
Verdict · setup score 55/100 · data Sep 10 close · 1 session old

Stand aside — setup invalidated

Setup score 55, but price closes below stop $830.47 — stand aside until the condition resets.

Review six verdicts Inspect chart
Earnings

Normal technical setup

Next earnings Monday, October 26, 2026 Report time not confirmed by the source

Deterministic evidence

REGN-1.78%
Sector proxy · XLV-0.55%
Broad market · SPY-0.60%
Same completed session window ending 2026-09-10. REGN was -1.23 points vs XLV. -1.18 points vs SPY.

Session internals Weak

Rule: closed flat-to-down and in the bottom third of the range. Judged on internals, not on the size of the move.

Vs prior close-1.78% From the open-1.21% Range position9% GapNo gap
QQQ confirmationConfirming (-1.06%) SMH confirmationConfirming (-2.44%)
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

Ask a Legend to interpret this evidence → Commentary only — never scanner evidence or a sizing recommendation.

Price $793.26 -1.8% Sep 10 close
52W High $859.34 7.7% below high
Wks Since High 0w
Base Depth 7.8%
RS Rank 59 percentile of scan
SMA 50 $748.32
Avg Vol 743,833
Rel Vol (Sep 10) 0.71×
More stats
52W Low $541.00
Tight Wks 0
Base B3
SMA 200 $733.40
RS Line vs High -11.9%
RS Line Slope +1.0% ▲
Group Rank #27/58
ADR% 2.2%
ATR(14) $19.82 (2.5%)
Vol Pace (live) N/A
U/D Vol 0.86
A/D Days 25A / 9D
A/D Rating A+
VDU Bars 0/10 d
Earnings in 44d
Position in 52-week range 79thpercentile of the 52-week range
$541.00low
$859.34high

REGN Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for REGN.

Create Free Account

Technical Analysis Report Card

$REGN · $793.26 · as of 2026-09-10 · multi-factor read
75
/ 100
Technicals 75/100
Reference read from price & volume only — the verdict at the top of the page decides the action.

Trend · Daily / Weekly / Monthly

Daily ▬ Sideways / consolidating
Weekly ▲ Uptrend
Monthly ▲ Uptrend

Moving Averages

50-day$748.32 ↑
100-day$705.11 ↑
200-day$733.40 ↑
Golden Cross (fresh)

RSI (14)

Reading49.1 · Neutral

Neutral — momentum is balanced between buyers and sellers.

MACD (12/26/9)

StateWeakening
Histogram-7.605

Weakening — MACD slipped below its signal line. Histogram contracting.

Bollinger Bands (20,2)

%B / Width13% · 8.3%

Near the lower band — under pressure or oversold.

Volume · Buyer vs Seller

Up/Down vol0.86 · Neutral
Rel volume0.71×

Balanced — up/down volume is roughly even; no clear hand. Recent volume is easing versus its baseline.

Support & Resistance

R · $815.00swing level
R · $847.00swing level
R · $859.3452-week high
Price · $793.26now
S · $779.08swing level
S · $753.79swing level
S · $737.34swing level

Fibonacci · Uptrend swing

23.6% ◄ price here$796.13
38.2%$757.03
50.0%$725.43
61.8%$693.83
78.6%$648.83

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for REGN — plus the full 500+ symbol scanner and Ask-the-Legends chat.
Start your 7-day free trial →
Weekly uptrendMonthly uptrendAbove 200-day MA50/200 bullish
Want this read in a legend's voice? Ask a Legend about REGN
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.

Council consensus: 4 of 6 legends are Watching — building, not yet a confirmed buy.
Minervini
Avoid
Minervini C

Trend-template read: fails 150-day MA > 200-day MA.

Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $793.26, MA150 $725.20, MA200 $733.40
1.4 50-day MA > 150-day MA AND 200-day MAMA50 $748.32, MA150 $725.20, MA200 $733.40
Failing evidence
1.2 150-day MA > 200-day MAMA150 $725.20 vs MA200 $733.40
1.8 RS rank ≥ 70 (prefer ≥ 85)RS rank 67
7/12 checks
Method → Playbook → Ask →
O'Neil
Avoid
O'Neil D

CANSLIM read: fails L: RS rank ≥ 80 (IBD leadership).

Passing evidence
C: Quarterly EPS acceleration ≥ 25%CANSLIM grade B
N: Near 52-week high or RS line new high7.7% below high | RS line new high: False
Failing evidence
L: RS rank ≥ 80 (IBD leadership)RS rank 67
A: Annual earnings & revenue qualityRev +1.0%
3/8 checks
Method → Playbook → Ask →
Weinstein
Watch
Weinstein C

Stage-analysis read: Stage 2 is present; 2 supporting checks need improvement.

Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $793.26 vs MA200 $733.40
Failing evidence
Volume expansion above averageVolume ratio 0.71x
Weekly price coiling (Stage 2 consolidation)Tightening weekly range confirms base
5/7 checks
Method → Playbook → Ask →
Livermore
Watch
Livermore B

Pivotal-point read: constructive evidence is present, but relative strength is unresolved.

Passing evidence
Price$793.26
Distance from 52-week high7.7% below high
Failing evidence
Relative strengthRS 67
Volume vs average0.71x
3/6 checks
Method → Playbook → Ask →
Darvas
Watch
Darvas B

Box-theory read: constructive evidence is present, but relative strength is unresolved.

Passing evidence
Price$793.26
Distance from 52-week high7.7% below high
Failing evidence
Relative strengthRS 67
Volume vs average0.71x
3/6 checks
Method → Playbook → Ask →
Wyckoff
Watch
Wyckoff B

Supply-and-demand read: constructive evidence is present, but relative strength is unresolved.

Passing evidence
Price$793.26
Distance from 52-week high7.7% below high
Failing evidence
Relative strengthRS 67
Volume vs average0.71x
3/6 checks
Method → Playbook → Ask →
Base & Breakout
Breakout follow-through

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

Unlock Base & Breakout Tracking
RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▲ Rising
123RS Line (52W)
Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net +10 A+
A: 18 D: 8 Net: +1065 sessions
Minervini · Grade Card
Fundamentals & leadership quality — Minervini’s published criteria · 2/7 met
C 2/7 criteria
Separate score from the Minervini Trend Template (6/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
✗ EPS acceleration ≥25% QoQ —
✗ Revenue growth ≥20% YoY +1%
✗ Gross margin ≥30% —
✗ ROE ≥17% —
✗ RS rating ≥80 (leadership) 67
✓ Stage 2 uptrend (Weinstein) Stage 2
✓ Within 25% of 52W high -7.7%

Method Playbook

Trade it like Minervini EXACT LEVELS · PRO
Minervini C · Avoid — The deterministic methodology check is Avoid; wait until the blocking criteria are resolved.
Pivot
Pro level
Published-method rule: Use the tight base's structural pivot; the setup must retain Trend Template leadership into the trigger.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro level
Published-method rule: Require a decisive move through the pivot with volume confirmation, and do not initiate more than 5% above it.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro level
Published-method rule: Start at the tighter structural invalidation; the initial loss limit must not exceed roughly 7–8% from entry.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-based
Published-method rule: Hold the initial stop until the trade proves itself; near +1R move to breakeven, then trail a higher low or rising 10/21-day average once well extended.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro level
Published-method rule: Exit when the structural stop or a meaningful higher-low/short-term trend violation fires; never widen the stop.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →

Pattern Analysis

Cup & Handle Historical replay: +20% before −8% within 40 sessions: 21% (n=53) · source bars 2025-03-17–2026-09-04 · avg +1.9% per setup (+0.24R) ⚠ 3rd-stage base ⚠ Bearish RSI divergence ⚠ Not actionable yet
55 setup score
RS Score 67
Trend template 6/8
CANSLIM 66.5* (B)
27.2% cup depth 7.8% handle
Why This Setup?
cup handle Cup & Handle · schematic

depth=27.2%, handle_pb=7.8%, lips_diff=5.1%, upper_half=yes, u_shape=yes, near_pivot=no, orderly=yes | Moderate trend (6/8) | Good RS (67) | High-confidence pattern (82%) | Stage 2 | Readiness 56/100 (early) | CANSLIM 66.5 (B) | ⚠ 3rd-stage base; Bearish RSI divergence; Not actionable yet

Ask a Legend ▾
The Universal Edge Check · context only

What the setup still has going for it, recorded for later. The verdict above stands — these principles do not overrule it.

2/7 universals met
  • A relative-strength leader — not met RS rank 59 — laggard
  • Risk is defined — not met No stop — undefined risk
  • Asymmetric reward — partly met No target set
  • Not chasing (in range) — partly met Pivot distance unknown
  • Volume confirms — partly met 0.7× average — light
  • Clear of earnings — met in 44 days
  • In a confirmed uptrend — met Stage 2 · Trend template 6/8
Why these seven? → The Universal Edge

Minervini Trend Template

6/8

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $793.26 vs SMA150 $725.20 / SMA200 $733.40
SMA 150 above SMA 200 SMA150 $725.20 vs SMA200 $733.40
SMA 200 trending up Slope +15.50 over 20 days
SMA 50 above SMA 150 & 200 SMA50 $748.32
Price above SMA 50 $793.26 vs SMA50 $748.32
30%+ above 52-week low +46.6% from $541.00
Within 25% of 52-week high -7.7% from $859.34
RS score above 70 RS 67

Fundamentals

52W Range
79%
Mkt Cap SEC
74.5B
Rev YoY
+1%
EPS TTM
$41.48
P/E TTM
19.1x
Float
94M

Company

Company profile
Regeneron Pharmaceuticals, Inc.
REGN · NASDAQ · Health Technology · Pharmaceuticals: Major
Track all markets on TradingView
O'Neil · Grade Card
CANSLIM — current EPS, annual EPS, new highs, supply, leader RS, inst. sponsorship, market
B 66.5* CANSLIM * disqualified on M
C · Curr. EPS
100
A · Annual EPS
56
N · New Highs
100
S · Supply/Demand
70
L · Leader RS
67
I · Inst. Spons.
50
M · Market
30

Weekly Context

Multi-timeframe signals from weekly bars
W. Trend
7/8
W. RS
86
W. Support
$591.52
W. Resist
$859.34
Weekly Structure

Scan History

20× streak
Sep 09: 55 (Cup & Handle)Sep 10: 55 (Cup & Handle)Sep 11: 55 (Cup & Handle)55
Sep 11
Cup & Handle ✓ Gate
55
Sep 10
Cup & Handle ✓ Gate
55 0.0%
Sep 09
Cup & Handle ✓ Gate
55 -1.8%

Get the full picture on REGN

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 500+ symbols daily.

Start 7-Day Free Trial